ARTICLE | Management Tracks
Plus: Senhwa hires Jason Huang as CMO, and updates from Egle and The Jackson Laboratory
By Gunjan Ohri, Data Content Analyst
May 14, 2024 1:23 AM UTC
John Milad became CEO of ERS Genomics Ltd., a CRISPR licensing company. Milad was CEO of Quanta Dialysis Technologies Ltd. for over13 years, and then became a partner and co-head of healthcare ventures at Downing LLP. ERS Genomics provides access to the CRISPR/Cas9 CVC intellectual property held by Emmanuelle Charpentier.
DNA damage response therapies company Senhwa Biosciences Inc. (TPEx:6492) hired Jason Huang as CMO, effective June 3. Huang was regional therapeutic area expert at Johnson & Johnson Innovative Medicine unit of Johnson & Johnson (NYSE:JNJ)…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652420/john-milad-named-ceo-of-crispr-play-ers-genomics